Latest Insider Transactions at Perrigo CO PLC (PRGO)
This section provides a real-time view of insider transactions for Perrigo CO PLC (PRGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PERRIGO Co plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PERRIGO Co plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2022
|
Thomas Farrington EVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+22.34%
|
$266,400
$37.23 P/Share
|
|
Mar 04
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,306
-7.85%
|
$233,322
$37.23 P/Share
|
|
Mar 04
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,410
+8.49%
|
$200,170
$37.23 P/Share
|
|
Mar 04
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
8,805
+30.01%
|
$325,785
$37.23 P/Share
|
|
Mar 04
2022
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,209
-9.28%
|
$192,733
$37.23 P/Share
|
|
Mar 04
2022
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,012
+10.17%
|
$185,444
$37.23 P/Share
|
|
Mar 04
2022
|
Robert Willis EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
4,999
+25.06%
|
$184,963
$37.23 P/Share
|
|
Feb 07
2022
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
2,059
-13.82%
|
$74,124
$36.95 P/Share
|
|
Feb 07
2022
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
4,297
+22.38%
|
$154,692
$36.95 P/Share
|
|
Dec 17
2021
|
Todd W Kingma Executive VP, General Counsel |
BUY
Open market or private purchase
|
Direct |
3,000
+5.47%
|
$111,000
$37.55 P/Share
|
|
Dec 16
2021
|
Geoffrey M. Parker Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+31.49%
|
$180,000
$36.85 P/Share
|
|
Dec 16
2021
|
Bradley A Alford Director |
BUY
Open market or private purchase
|
Direct |
13,000
+35.16%
|
$468,000
$36.88 P/Share
|
|
Dec 06
2021
|
Svend Andersen EVP & President CHCI |
BUY
Open market or private purchase
|
Indirect |
3,655
+12.29%
|
$135,235
$37.1 P/Share
|
|
Dec 03
2021
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
27,500
+42.18%
|
$990,000
$36.03 P/Share
|
|
Dec 02
2021
|
Rolf A Classon Director |
BUY
Open market or private purchase
|
Direct |
2,800
+13.83%
|
$98,000
$35.67 P/Share
|
|
Aug 12
2021
|
Katherine C. Doyle Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,706
-48.0%
|
$110,946
$41.28 P/Share
|
|
Aug 12
2021
|
Katherine C. Doyle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,637
+50.0%
|
$231,117
$41.28 P/Share
|
|
May 07
2021
|
Adriana Karaboutis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,786
-21.05%
|
$117,012
$42.96 P/Share
|
|
May 07
2021
|
Adriana Karaboutis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+30.49%
|
$243,768
$42.96 P/Share
|
|
May 07
2021
|
Rolf A Classon Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,483
-19.22%
|
$146,286
$42.96 P/Share
|
|
May 07
2021
|
Rolf A Classon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,255
+28.59%
|
$304,710
$42.96 P/Share
|
|
May 07
2021
|
Donal O'Connor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,786
-17.15%
|
$117,012
$42.96 P/Share
|
|
May 07
2021
|
Donal O'Connor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+26.33%
|
$243,768
$42.96 P/Share
|
|
May 07
2021
|
Geoffrey M. Parker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,786
-19.56%
|
$117,012
$42.96 P/Share
|
|
May 07
2021
|
Geoffrey M. Parker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+28.95%
|
$243,768
$42.96 P/Share
|
|
May 07
2021
|
Jeffrey B Kindler Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,786
-20.25%
|
$117,012
$42.96 P/Share
|
|
May 07
2021
|
Jeffrey B Kindler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+29.67%
|
$243,768
$42.96 P/Share
|
|
May 07
2021
|
Erica L Mann Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,019
-34.67%
|
$126,798
$42.96 P/Share
|
|
May 07
2021
|
Erica L Mann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+39.99%
|
$243,768
$42.96 P/Share
|
|
May 07
2021
|
Theodore R. Samuels Ii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+22.41%
|
$243,768
$42.96 P/Share
|
|
May 07
2021
|
Bradley A Alford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,786
-20.24%
|
$117,012
$42.96 P/Share
|
|
May 07
2021
|
Bradley A Alford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+29.66%
|
$243,768
$42.96 P/Share
|
|
Apr 05
2021
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,964
+27.99%
|
$158,560
$40.39 P/Share
|
|
Mar 17
2021
|
Geoffrey M. Parker Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+48.54%
|
$102,500
$41.29 P/Share
|
|
Mar 10
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Open market or private sale
|
Direct |
2,662
-18.5%
|
$109,142
$41.23 P/Share
|
|
Mar 08
2021
|
Svend Andersen EVP & President CHCI |
SELL
Payment of exercise price or tax liability
|
Direct |
47
-0.34%
|
$1,927
$41.82 P/Share
|
|
Mar 08
2021
|
Svend Andersen EVP & President CHCI |
BUY
Grant, award, or other acquisition
|
Direct |
5,543
+28.74%
|
$227,263
$41.82 P/Share
|
|
Mar 08
2021
|
Todd W Kingma Executive VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,166
-4.61%
|
$88,806
$41.82 P/Share
|
|
Mar 08
2021
|
Todd W Kingma Executive VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
7,571
+13.88%
|
$310,411
$41.82 P/Share
|
|
Mar 08
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-8.94%
|
$48,339
$41.82 P/Share
|
|
Mar 08
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
4,121
+23.81%
|
$168,961
$41.82 P/Share
|
|
Mar 08
2021
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,083
-16.07%
|
$44,403
$41.82 P/Share
|
|
Mar 08
2021
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+23.6%
|
$85,362
$41.82 P/Share
|
|
Mar 08
2021
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,343
-17.05%
|
$55,063
$41.82 P/Share
|
|
Mar 08
2021
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
697
+15.05%
|
$28,577
$41.82 P/Share
|
|
Mar 08
2021
|
Robert Willis EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,884
+32.35%
|
$77,244
$41.82 P/Share
|
|
Mar 08
2021
|
Thomas Farrington EVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,639
-9.11%
|
$67,199
$41.82 P/Share
|
|
Mar 08
2021
|
Thomas Farrington EVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
3,758
+17.28%
|
$154,078
$41.82 P/Share
|
|
Mar 08
2021
|
Sharon Kochan EVP & President Rx |
BUY
Grant, award, or other acquisition
|
Direct |
4,721
+11.98%
|
$193,561
$41.82 P/Share
|
|
Mar 05
2021
|
Svend Andersen EVP & President CHCI |
BUY
Payment of exercise price or tax liability
|
Direct |
55
+0.29%
|
$2,255
$41.04 P/Share
|